IndraLab

Statements


| 5

reach
"In contrast, rosiglitazone treatment significantly attenuated urinary ACE2 activity in db/db mice."

reach
"However, in type 2 diabetic mice, rosiglitazone normalized hyperglycemia, attenuated renal injury, and decreased urinary ACE2 excretion and renal ADAM17 protein expression but, unlike insulin, did not affect renal ACE2 expression."

reach
"Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion."

reach
"Urinary ACE2 was significantly attenuated by insulin, rosiglitazone and metformin with/without exercise, the agents known to correct high blood glucose concentrations (23-26)."

reach
"Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion."